Investor Relations

2019 News Releases

Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012
DateTitle  
01/17/19Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANN ARBOR, Mich.--(BUSINESS WIRE)--Jan. 17, 2019-- Millendo Therapeutics, Inc. (“Millendo” or the “Company”) (NASDAQ: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced today that on January 15, 2019, the Compensation Committee of the Board of Directors approved, effective as of January 15, 2019, the grant of inducement stock options to purchase a total of 51,200 shares of the Com... 
 Printer Friendly Version